Search clinical trials for: GLP-2

Total 47651 results

University of Copenhagen
Gentofte Hospital, Denmark

Recruiting

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function (H-21044858)

Incretin Effect

Denmark
University of Bath
Arla Foods

Completed

The Dose Response of Calcium Co-ingested With Protein on GLP-1 Concentrations (PROCAL)

GLP-1 Concentration

United Kingdom
GlyPharma Therapeutics
VectivBio AG

Completed

Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency

SBS - Short Bowel Syndrome

Denmark
University of Copenhagen
Hvidovre University Hospital

Recruiting

Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury

Spinal Cord Injuries

Denmark
Glostrup University Hospital, Copenhagen

Unknown

Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

Short Bowel Syndrome

Denmark
Zealand Pharma
Profil Institut für Stoffwechselforschung GmbH

Recruiting

A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Safety and Tolerability

Germany
Zealand Pharma

Completed

A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Healthy

Germany
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Active, not recruiting

The Effect of Exogenous Glucagon-like Peptide 2 on Cholecystokinin-induced Gallbladder Emptying

Gallbladder

Denmark
Glostrup University Hospital, Copenhagen
Rigshospitalet, Denmark; University of Copenhagen

Unknown

The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans

Healthy

Denmark
University of Copenhagen
Hvidovre University Hospital

Completed

Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19

Type 2 Diabetes Mellitus

Denmark
University of Copenhagen
Hvidovre University Hospital

Completed

Gut Hormones and Bone Remodeling in Humans (KS-2) (KS-2)

Healthy

Denmark
University of Copenhagen
Hvidovre University Hospital

Completed

Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism. (KS-4-HypoPT)

Hypoparathyroidism

Denmark
University Hospital, Gentofte, Copenhagen

Completed

Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone? (GLANCE)

Glucose Metabolism Disorders | Endocrine or Metabolic Disease

Denmark
University Health Network, Toronto

Completed

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

Dyslipidemia

Canada
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1

Gut Microbiota | GLP-1

Mexico
Herlev Hospital
University of Copenhagen; The Danish Medical Research Council; The Danish Diabetes...

Completed

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Type 2 Diabetes Mellitus

Denmark
Adrian Vella

Completed

Dose-response Study of Exendin-9,39 on Glucose Metabolism

Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1

United States
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

Relationships Between GLP-2 and Markers of Bone Turnover Following Feeding (GLP-2)

Obesity

United Kingdom
University of Copenhagen
Rigshospitalet, Denmark

Completed

The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism (GA-17)

Blood Flow

Denmark
National Institute for Medical Research, Tanzania
London School of Hygiene and Tropical Medicine; University of Copenhagen; Queen...

Active, not recruiting

Enteropathy and Diabetes in HIV Patients (REEHAD)

Diabetes | HIV | Environmental Enteropathy

Tanzania
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy

Breast Cancer | Dyspepsia | Lung Cancer

Italy
VectivBio AG

Active, not recruiting

Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF (STARS)

Short Bowel Syndrome

United States, France, United Kingdom, Israel, Korea, Republic of, Germany, Japan, Taiwan, Sweden, Belgium, Spain, Czechia, Hungary, Norway, Italy, Argentina, Denmark, Poland
Shire

Completed

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

Short Bowel Syndrome

United States, Canada, Finland, Belgium, Italy, United Kingdom, Germany
Royal Devon and Exeter NHS Foundation Trust
University of Exeter

Completed

GLP-1 and Microvascular Function in Type 2 Diabetes (GLP-1ADDS)

Type 2 Diabetes

United Kingdom
Rigshospitalet, Denmark
Department of Cardiovascular and Renal Research, University of Southern Denmark

Completed

Acute Effects of GLP-1 on Renal Hemodynamics (GLP1RRBF)

The GLP-1-mediated Gut-kidney Axis

Denmark
Glostrup University Hospital, Copenhagen

Completed

GLP-2 (Glucagonlike Peptide-2) and Blood Flow

Regional Blood Flow

Denmark
AstraZeneca

Completed

A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients. (Bydureon)

Type 2 Diabetes Mellitus

Korea, Republic of
Charite University, Berlin, Germany
Takeda

Unknown

Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis (MatchedQoL)

Short Bowel Syndrome | Intestinal Failure

Germany
Anders Fink-Jensen, MD, DMSci

Recruiting

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Schizophrenia | Type 2 Diabetes | Metabolic Disturbance | Clozapine | Olanzapine | GLP-1

Denmark
Société des Produits Nestlé (SPN)

Completed

Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients

Healthy

Switzerland
Steno Diabetes Center Copenhagen

Unknown

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

Effect of Glucagon-like Peptide 2 on Gallbladder Motility

Denmark
Laniado Hospital

Terminated

Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

Diabetes Mellitus Type 2

Israel
GlyPharma Therapeutics
VectivBio AG

Completed

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Short Bowel Syndrome

Denmark
Alberta Children's Hospital
The Hospital for Sick Children; British Columbia Children's Hospital; Stollery...

Terminated

Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure (GLP-2-01)

Short Bowel Syndrome | Intestinal Failure

Canada
University of Copenhagen
Hvidovre University Hospital

Completed

Effects of Gut Peptides on Bone Remodeling (KS-3)

Healthy

Denmark
Zealand Pharma

Completed

A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570

Healthy

Germany
Tel Aviv University
Wolfson Medical Center

Unknown

Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes (GLP-1inT2D)

Type 2 Diabetes

Israel
Tina Vilsboll

Completed

The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Type 2 Diabetes

Denmark
Vanderbilt University Medical Center

Recruiting

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab (GLP-TEP)

Type 1 Diabetes

United States
University Health Network, Toronto

Completed

Plasma Lipoprotein Response to Glucagon-like Peptide-2 (GLP-2 Plasma)

Hyperlipidemias

Canada
Chinese PLA General Hospital

Unknown

Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
University of Tartu

Completed

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

Type 2 Diabetes

Estonia
ConjuChem

Completed

A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy (DM200-101)

Type 2 Diabetes Mellitus

Canada
University Hospital, Gentofte, Copenhagen
University of Copenhagen

Unknown

Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response

The Focus of This Study is to Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration.

Denmark
University of Copenhagen
Hvidovre University Hospital

Completed

Investigation of GLP-2 Mechanism of Action (GA-8)

Healthy

Denmark
University of Aarhus

Completed

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men

Myocardial Infarction | Stroke | Type 2 Diabetes

Denmark
Third Military Medical University

Unknown

Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment (Par-4；GLP-1)

GLP-1；Metformin；Telomere-telomerase System；Par-4

China
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

Type 2 Diabetes Mellitus

Brazil
Wu Qinan

Unknown

Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes

Type 2 Diabetes

China
Chang Gung Memorial Hospital

Completed

Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients (AGAC2)

Type 2 Diabetes Mellitus

Taiwan

Search clinical trials for: GLP-2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations